Panlin Capital Announces Second Closing for its Healthcare Venture Capital Fund; Has Raised a Total of RMB 1.5 Billion in the Last Two Years

/PRNewswire/ -- Recently, Panlin Capital announced that Hangzhou Panlin Xukang Fund, a venture capital fund focusing on innovative biopharmaceuticals,...

Related Keywords

Li Yuhui ,Zhejiang ,China ,Zhongyuan ,Jiangsu ,Shanghai ,Chengdu ,Sichuan ,Xiaoshan ,Anhui ,Dushi ,Shaanxi ,Hangzhou ,Kingstron Bio ,Dnano Metabio ,Hangzhou Panlin Xukang Fund ,Hangzhou Xiaoshan International Venture Capital ,Technology Innovation Investment Group ,Chengdu Panlin Xiangxu Fund ,Chasestone Group ,Panlin Xukang Fund ,Technology Innovation Group ,Panlin Capital ,Hangzhou Science ,Chengdu Science ,Zhongyuan Trust ,Xiaoshan District ,Dushi Pharmaceutical Supply Chain ,Best Biotech ,Ribo Life Science ,Virogin Biotech ,Founding Managing Partner ,